New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Walgreens Will Pay Nearly $6 Million to Settle FTC Deceptive Advertising Charges

In a continuing crackdown on companies making unproven claims about cold and flu remedies, the Federal Trade Commission has announced two more cases.

National pharmacy chain Walgreens has agreed to pay nearly $6 million to settle FTC charges that the company deceptively advertised “Wal-Born” – a line of dietary supplements similar to the Airborne cold-and-flu treatment – using the same kind of baseless claims that the supplements could prevent colds, fight germs, and boost the immune system.

In addition to the proposed Walgreens agreement, a federal court has approved a settlement in a separate case that will require a $565,000 payment by the two principal officers of Improvita Health Products Inc., the manufacturer of Walgreens’ “Wal-Born” and other supplements. The FTC suit against the corporate defendant, Improvita Health Products, Inc., remains in litigation.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.